epigral-ltd

Epigral Ltd Financials
Company Logo

Epigral Ltd Financial Statement

Epigral Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue631.61
Operating Expense447.63
Net Profit80.53
Net Profit Margin12.75
Earning Per Share19.38
EBIDTA162.02
Effective Tax Rate11.91

Epigral Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual1,929.19
Operating Expenses Annual1,447.98
Operating Profit Annual487.72
Interest Annual73.49
Depreciation123.56
Net Profit Annual195.79
Tax Annual94.88

Epigral Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning14.19
Cash Flow from Operations397.69
Cash Flow from Investing-401.10
Cash Flow from Financing-7.60
Cash Flow at the End3.18

Epigral Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)25.28
PBIT Margin (%)18.88
PBT Margin (%)18.62
Net PROFIT Margin (%)10.15
Return On Networth / Equity (%)16.85
Return On Networth /Employed (%)17.45
Return On Assets (%)9.34
Total Debt / Equity (X)0.67
Asset Turnover Ratio (%)0.92

Epigral Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual1,766.64
Total Current Assets Annual501.93
Non Current Assets Annual2,292.40
Total Shareholders Funds Annual1,254.09
Total Assets Annual2,794.33

Epigral Ltd Earning Calls

EPS (INR)

Expected

19.57

Reported

19.57

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Mar 2024

EPS beaten by 0.00%

Dec 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Dec 11, 2024, Epigral Ltd has a market capitalization of 4,553.69 Cr. Value Research classifies it as a Mid-Cap company.
No, Epigral Ltd is not debt-free with a debt-to-equity ratio of 0.77.
In FY 2023 , Epigral Ltd recorded a total revenue of approximately 1,929.19 Cr marking a significant milestone in the company's financial performance.
Epigral Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and 0.1% annually, respectively..
Epigral Ltd's current PE ratio is 23.26.
Epigral Ltd's ROCE averaged 23.8% from the FY ending March 2022 to 2024, with a median of 24.9%. It peaked at 30.2% in March 2023, reflecting strong capital efficiency over the period..
Epigral Ltd's latest EBIT is Rs. 364.16 Cr, surpassing the average EBIT of Rs. 459.96 Cr over the 5 years..
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions